Enrollment Ongoing with FT819 1XX CAR T-cell Product Candidate in Phase 1 Autoimmunity Study; Single-agent Cyclophosphamide Included as Alternative Conditioning Regimen First Patient Treated with ...
Fate Therapeutics (NASDAQ:FATE) just reported results for the second quarter of 2024. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings ...
Fate/Extra Record is a modern remake of Fate/Extra. It was originally announced in July 2020, and sporadic updates appeared until August 2022. The original game initially released for the PSP on July ...
Lasengle revealed the 2024 update roadmap for the English server of Fate/Grand Order. However, this is not a complete roadmap, as it only includes details between March and June 2024. From March 15, ...
Welcome to the Fate Therapeutics First Quarter 2024 Financial Results Conference Call [Operator Instructions]. This call is being webcast live on the Investors section of Fate's Web site at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results